[1] ORTH S R, RITZ E. The nephrotic syndrome[J]. N Engl J Med, 1998, 338(17):1202-1211. doi:  10.1056/NEJM199804233381707
[2] ROVIN B H, ADLER S G, BARRATT J, et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases[J]. Kidney Int, 2021, 100(4):753-779. doi:  10.1016/j.kint.2021.05.015
[3] 张春燕, 任晓蕾, 张晓红. 五酯胶囊对肾病综合征患者他克莫司血药浓度及临床疗效影响的文献分析[J]. 中国新药杂志, 2023, 32(11):1128-1131. doi:  10.3969/j.issn.1003-3734.2023.11.008
[4]

LI J L, LIU S, FU Q, et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients[J]. Pharmacogenomics, 2015, 16(12):1355-1365. doi:  10.2217/pgs.15.78
[5] 李沭, 张倩, 张爽, 等. 2018年中国医院治疗药物监测开展状况调查[J]. 中国药学杂志, 2019, 54(24):2087-2092. doi:  10.11669/cpj.2019.24.015
[6]

LECUN Y, BENGIO Y, HINTON G. Deep learning[J]. Nature, 2015, 521:436-444. doi:  10.1038/nature14539
[7] 陆晓玲, 陈冰. 机器学习在移植患者他克莫司个体化精准用药中的应用概述[J]. 药物流行病学杂志, 2023, 32(1):82-88.
[8] 宋学武, 高慧儿, 张弋. 基于人工智能的机器学习算法在个体化用药领域的应用进展[J]. 中国新药与临床杂志, 2021, 40(10):683-688.
[9]

BURLACU A, IFTENE A, JUGRIN D, et al. Using artificial intelligence resources in dialysis and kidney transplant patients: a literature review[J]. Biomed Res Int, 2020, 2020:9867872.
[10]

CHEN H Y, CHEN T C, MIN D I, et al. Prediction of tacrolimus blood levels by using the neural network with genetic algorithm in liver transplantation patients[J]. Ther Drug Monit, 1999, 21(1):50-56. doi:  10.1097/00007691-199902000-00008
[11]

BORDIN N, DALLAGO C, HEINZINGER M, et al. Novel machine learning approaches revolutionize protein knowledge[J]. Trends Biochem Sci, 2023, 48(4):345-359. doi:  10.1016/j.tibs.2022.11.001
[12] 袁天蔚, 薛淮, 杨靖, 等. 从战略规划与科技布局看国内外人工智能医学应用的发展现状[J]. 生命科学, 2022, 34(8):974-982.
[13]

Sarker I H. Machine Learning: Algorithms, Real-World Applications and Research Directions[J]. SN Computer Science, 2021, 2(3):160. doi:  10.1007/s42979-021-00592-x
[14]

Ganaie M A, Hu M, Malik A K, et al. Ensemble deep learning: A review[J]. Engineering Applications of Artificial Intelligence, Oxford: Pergamon-Elsevier Science Ltd, 2022, 115: 105151.
[15] 张颖, 于泽, 许本善, 等. 人工智能指导个体化用药的研究与实践[J]. 中国临床药学杂志, 2022, 31(2):151-156.
[16]

ZHENG P, YU Z, LI L R, et al. Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence[J]. Front Pharmacol, 2021, 12:727245. doi:  10.3389/fphar.2021.727245
[17]

HUANG Q B, LIN X B, WANG Y, et al. Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: a combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction[J]. Front Pharmacol, 2022, 13:942129. doi:  10.3389/fphar.2022.942129
[18]

MO X L, CHEN X J, WANG X G, et al. Prediction of tacrolimus dose/weight-adjusted trough concentration in pediatric refractory nephrotic syndrome: a machine learning approach[J]. Pharmgenomics Pers Med, 2022, 15:143-155.
[19]

MO X L, CHEN X J, IEONG C, et al. Early prediction of tacrolimus-induced tubular toxicity in pediatric refractory nephrotic syndrome using machine learning[J]. Front Pharmacol, 2021, 12:638724. doi:  10.3389/fphar.2021.638724
[20]

SHAO B, QU Y Y, ZHANG W, et al. Machine learning-based prediction method for tremors induced by tacrolimus in the treatment of nephrotic syndrome[J]. Front Pharmacol, 2022, 13:708610. doi:  10.3389/fphar.2022.708610
[21]

MO X L, CHEN X J, ZENG H S, et al. Tacrolimus in the treatment of childhood nephrotic syndrome: machine learning detects novel biomarkers and predicts efficacy[J]. Pharmacotherapy, 2023, 43(1):43-52. doi:  10.1002/phar.2749
[22]

YUAN W J, SUI L, XIN H L, et al. Discussion on machine learning technology to predict tacrolimus blood concentration in patients with nephrotic syndrome and membranous nephropathy in real-world settings[J]. BMC Med Inform Decis Mak, 2022, 22(1):336. doi:  10.1186/s12911-022-02089-w
[23] 周虎子威, 张云静, 于玥琳, 等. 机器学习方法在预测麻精药品不合理使用风险中的应用现状和思考[J]. 药物流行病学杂志, 2023, 32(4):446-457.